Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

11 June 2007

Limited predictive value of real-time quantitative PCR cytomegalovirus monitoring in the blood. Fatal CMV pneumonia in an autologous stem cell transplant recipient previously treated with alemtuzumab.

Kazimierz Halaburda, Barbara Nasilowska-Adamska, Piotr Grabarczyk, Andrzej Szczepinski, Tomasz Szpila, Krzysztof Warzocha, Bozena Marianska

Ann Transplant 2007; 12(2): 37-40 :: ID: 514522

Abstract

Background: Patients treated with alemtuzumab are at very high risk for cytomegalovirus (CMV) reactivation. Also, in those who develop reactivation short time before stem cell transplantation the risk of fatal complications is extremely high.
Case Report: We describe a 21-year-old patient with anaplastic large T-cell lymphoma who developed CMV reactivation after alemtuzumab treatment and received high-dose chemotherapy with autologous stem cell transplantation for progressive disease and severe bone marrow aplasia. Blood samples of the patient were tested regularly for CMV reactivation with real-time quantitative PCR. Even though it is considered the most sensitive available method it did not allow us to predict in advance development of fatal CMV pneumonia in this patient.
Conclusions: The case report illustrates limitations of prognostic value of quantitative real-time PCR CMV assessment in blood samples.

Keywords: cytomegalovirus pneumonia, alemtuzumab, autologous stem cell transplantation, real-time PCR

Add Comment 0 Comments

In Press

Original article  

Survival Analysis of Liver Transplants in Patients with Acute Liver Failure from Acetaminophen and Mushroom...

Ann Transplant In Press; DOI: 10.12659/AOT.946485  

Original article  

Medication Adherence Among Pediatric Post-Heart Transplant Patients in a Tertiary Care Hospital

Ann Transplant In Press; DOI: 10.12659/AOT.946905  

Original article  

Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantati...

Ann Transplant In Press; DOI: 10.12659/AOT.947186  

Most Viewed Current Articles

03 Jan 2023 : Original article   6,423

Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...

DOI :10.12659/AOT.938467

Ann Transplant 2023; 28:e938467

16 May 2023 : Original article   6,074

Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...

DOI :10.12659/AOT.939258

Ann Transplant 2023; 28:e939258

15 Aug 2023 : Review article   6,033

Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation

DOI :10.12659/AOT.939750

Ann Transplant 2023; 28:e939750

17 Jan 2023 : Original article   5,201

Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation i...

DOI :10.12659/AOT.938595

Ann Transplant 2023; 28:e938595

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358